Preoperative platelet distribution width-to-platelet count ratio as a prognostic factor in patients with glioblastoma multiforme

References

• Auezova R, Ryskeldiev N, Doskaliyev A, et al. Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas. OTT 2016;9:6111–7.
   Google Scholar
• Baran O, Kemerdere R, Sukru Korkmaz T, Kayhan A, Tanriverdi T. Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis? Medicine 2019;98:e18306.
   PubMed Web of Science ®Google Scholar
• Cheng S, Han F, Wang Y, et al. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. BMC Gastroenterol 2017;17:163.
   PubMed Web of Science ®Google Scholar
• Li N, Diao Z, Huang X, Niu Y, et al. Increased platelet distribution width predicts poor prognosis in melanoma patients. Sci Rep 2017;7:1–6.
   PubMed Web of Science ®Google Scholar
• Mandaliya H, Jones M, Oldmeadow C, et al. 462P Prognostic importance of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR) and advanced lung cancer inflammation index (ALI) at diagnosis and post treatment in elderly with stage IV NSCLC. Annals of Oncology 2017;28:x142.
   PubMed Web of Science ®Google Scholar
• Mason M, Maurice C, McNamara MG, et al. Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. J Neurooncol 2017;132:463–71.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Abe M, Takumi Y, et al. The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer. PloS One 2017;12:e0189166.
   PubMed Web of Science ®Google Scholar
• Gu M, Zhai Z, Huang L, et al. Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer 2016;23:752–60.
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen Z, Wang P, et al. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumor Biol 2016;37:9323–31.
   PubMedGoogle Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Bao Y, Yang M, Jin C, et al. Preoperative hematologic inflammatory markers as prognostic factors in patients with glioma. World Neurosurg 2018;119:e710–e716.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Immunity, Inflammation, and Cancer. Cell 2010;140:883–99.
   Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? The Lancet 2001;357:539–45.
   PubMed Web of Science ®Google Scholar
• Khan AA, Akritidis G, Pring T, et al. The neutrophil-to-lymphocyte ratio as a marker of lymph node status in patients with rectal cancer. Oncology 2016;91:69–77.
   PubMed Web of Science ®Google Scholar
• Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol 2017;35:261–70.
   PubMed Web of Science ®Google Scholar
• Müller I, Munder M, Kropf P, et al. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol 2009;30:522–30.
   PubMed Web of Science ®Google Scholar
• Frelinger Iii AL, et al. Platelet-rich plasma stimulated by pulse electric fields: platelet activation, procoagulant markers, growth factor release and cell proliferation. Platelets 2016;27:128–35.
   PubMed Web of Science ®Google Scholar
• van der Loo B, Martin JF. A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999;19:672–9.
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood 2015;126:582–8.
   PubMed Web of Science ®Google Scholar
• Kang DW, Min DS. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFκB signaling pathway and enhances invasion of breast cancer cells. Cancer Letters 2010;294:125–33.
   PubMed Web of Science ®Google Scholar
• Sayit AT, Gunbey PH, Terzi Y. Is the mean platelet volume in patients with acute cholecystitis an inflammatory marker? J Clin Diagn Res 2015;9:TC05–TC07.
   PubMed Web of Science ®Google Scholar
• Osselaer J-C, Jamart J, Scheiff J-M. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 1997;43:1072–6.
   PubMed Web of Science ®Google Scholar
• Dinc B. New parameter in diagnosis of acute appendicitis: platelet distribution width. WJG 2015;21:1821.
   PubMed Web of Science ®Google Scholar
• Cetin M, Bakirci EM, Baysal E, et al. Increased platelet distribution width is associated with ST-segment elevation myocardial infarction and thrombolysis failure. Angiology 2014;65:737–43.
   PubMed Web of Science ®Google Scholar
• Wang F, Meng Z, Li S, et al. Platelet distribution width levels can be a predictor in the diagnosis of persistent organ failure in acute pancreatitis. Gastroenterology Research and Practice 2017;2017:1–6.
   Web of Science ®Google Scholar
• Shen J, Ran ZH, Zhang Y, et al. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis. Thrombosis Research 2009;123:604–11.
   PubMed Web of Science ®Google Scholar
• De Luca G, Venegoni L, Iorio S, et al. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study Novara Atherosclerosis Study Group. Platelets 2010;21:508–14.
   PubMed Web of Science ®Google Scholar
• Vagdatli E, et al. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010;14:28.
   PubMed Web of Science ®Google Scholar
• Cho SY, Yang JJ, You E, et al. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2013;24:375–7.
   PubMed Web of Science ®Google Scholar
• Inagaki N, Kibata K, Tamaki T, et al. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer 2014;83:97–101.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Tokuno J, Ueda Y, et al. Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer. Molecular and Clinical Oncology 2015;3:197–201.
   PubMed Web of Science ®Google Scholar
• Wan S, Lai Y, Myers RE, et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Canc 2013;44:293–304.
   PubMedGoogle Scholar
• Matsuo K, Tang SH, Sharifi B, et al. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line. J Clin Endocrinol Metab 1993;77:996–1004.
   PubMed Web of Science ®Google Scholar
• Kayacan O. Impact of TNF-α and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. American Journal of Clinical Oncology 2006;29:328–35.
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Growth factors and hematopoietic cell fate. A new feature: controversies in hematology. Blood 1998;92:345–4.
   PubMed Web of Science ®Google Scholar